RECRUITING

BladdEr Full OR Empty for Pelvic Radiation Therapy

Talk to us

Conditions

Pelvic Neoplasmmalignancy of the pelvisbladderradiation therapy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The present study evaluates empty and full bladder protocols for radiation therapy of genitourinary (GU), gynecological (Gyn), and gastrointestinal (GI) malignancies of the pelvis.

Official Title

BladdEr Full OR Empty for Pelvic Radiation Therapy

Quick Facts

Study Start:2024-11-19
Study Completion:2029-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06651697

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provision of signed and dated informed consent form
  2. * Stated willingness to comply with all study procedures and availability for the duration of the study
  3. * Persons, aged at least 18 years
  4. * Deemed eligible to undergo curative intent radiation therapy for primary GU, GI, or Gyn malignancy of the pelvis.
  5. * For participants able to become pregnant: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation
  6. * For participants able to cause a pregnancy: use of condoms or other methods to ensure effective contraception with partner
  1. * Pregnancy
  2. * Tumor invading the bladder, as judged by the enrolling physician based on available clinical information
  3. * Contraindications to radiotherapy, including Crohn's disease and active connective tissue disorders such as scleroderma or uncontrolled lupus
  4. * Prior radiation therapy to an area requiring treatment in the present study

Contacts and Locations

Study Contact

Tyler Seibert, MD, PhD
CONTACT
858 822 5354
CancerCTO@health.ucsd.edu
Rana McKay, MD
CONTACT
858 822 5354
CancerCTO@health.ucsd.edu

Principal Investigator

Tyler Seibert, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Diego

Study Locations (Sites)

University of California, San Diego
San Diego, California, 92093
United States

Collaborators and Investigators

Sponsor: University of California, San Diego

  • Tyler Seibert, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-19
Study Completion Date2029-12

Study Record Updates

Study Start Date2024-11-19
Study Completion Date2029-12

Terms related to this study

Keywords Provided by Researchers

  • malignancy of the pelvis
  • bladder
  • radiation therapy

Additional Relevant MeSH Terms

  • Pelvic Neoplasm